Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 8, 2010, Pages 1193-1195

  Pudil, Radek ^a   Vašatová, Martina ^a   Lenčo, Juraj ^b   Tichý, Miloš ^a   Řeháček, Vít ^a   Fučíková, Alena ^b   Horáček, Jan M ^b   Vojáček, Jan ^a   Pleskot, Miloslav ^a   Stulík, Jiří ^b   Palička, Vladimír ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

glycogen phosphorylase BB; hypertrophic cardiomyopathy; left ventricle mass; pulmonary artery wedge pressure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; GLYCOGEN PHOSPHORYLASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; CLINICAL ARTICLE; DISEASE MARKER; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; LETTER; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL; PULMONARY ARTERY;

AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; GLYCOGEN PHOSPHORYLASE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE;

EID: 77954600580     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.231     Document Type: Letter

References (10)

1. Cambronero F, Marín F, Roldán V, Hernández-Romero D, Valdés M, Lip GY. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur Heart J 2009;30:139-151
2. Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, et. al. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart 2003;89:659-660
3. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, et. al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-824
4. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann V, Krause EG et. al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction. Lancet 1993;341:1032-1033
5. Peetz D, Post F, Schinzel H, Schweigert R, Schollmayer C, Steinbach K, et. al. Glycogen phosphorylase BB in acute coronary syndromes. Clin Chem Lab Med 2005;43:1351-1358
6. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et. al. American College of Cardiology/ European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. Eur Heart J 2003; 24:1965-1991
7. Sahn DJ, DeMaria A, Kisso J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083
8. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann V, Krause EG, et. al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995;41:966-978
9. Mair J. Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage. Clin Chim Acta 1998;272:79-86.
10. Knaapen P, Germans T, Camici PG, Rimoldi OE, ten Cate FJ, ten Berg JM, et. al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;294:H986-93.